Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndrome

Simon D J Gibbs1, Kirsten E Herbert, Christopher McCormack

  • 1Haematology Service, Peter MacCallum Cancer Centre, Melbourne, Australia.